Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Jankowski

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Proteomics|November 3, 2020
Proteomic Biomarkers to Guide Stratification for Covid-19 Treatment: Exemplifying a Path Forward Toward Implementation?Joachim Jankowski
Kidney International|March 22, 2023
Fosl1: friend or foe?Shruti Bhargava, Joachim Jankowski
Kidney International|August 2, 2008
Does an apple a day put hypertension in play?Joachim Jankowski, Thomas Günthner
Toxins|June 18, 2020
Editorial on the Special Issue "Comorbidities in Chronic Kidney Disease"Heidi Noels, Joachim Jankowski
Clinical Kidney Journal|August 20, 2021
A history of uraemic toxicity and of the European Uraemic Toxin Work Group (EUTox)Raymond Vanholder, Angel Argilés, Joachim Jankowski, et al.
Molecular Aspects of Medicine|August 18, 2021
Irreversible post-translational modifications - Emerging cardiovascular risk factorsZhuojun Wu, Vera Jankowski, Joachim Jankowski
Frontiers in Immunology|July 29, 2015
Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its ComorbiditiesPrathibha Reddy Gajjala, Maryam Sanati, Joachim Jankowski
Seminars in Dialysis|August 28, 2009
Proteomics in uremia and renal diseaseHarald Mischak, Ziad A Massy, Joachim Jankowski
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2015
Body fluid peptide and protein signatures in diabetic kidney diseasesJoachim Jankowski, Joost P Schanstra, Harald Mischak
Nature Reviews. Nephrology|May 11, 2021
Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterationsHeidi Noels, Michael Lehrke, Raymond Vanholder, et al.
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Proteomics|November 3, 2020
Proteomic Biomarkers to Guide Stratification for Covid-19 Treatment: Exemplifying a Path Forward Toward Implementation?Joachim Jankowski
Kidney International|March 22, 2023
Fosl1: friend or foe?Shruti Bhargava, Joachim Jankowski
Kidney International|August 2, 2008
Does an apple a day put hypertension in play?Joachim Jankowski, Thomas Günthner
Toxins|June 18, 2020
Editorial on the Special Issue "Comorbidities in Chronic Kidney Disease"Heidi Noels, Joachim Jankowski
Clinical Kidney Journal|August 20, 2021
A history of uraemic toxicity and of the European Uraemic Toxin Work Group (EUTox)Raymond Vanholder, Angel Argilés, Joachim Jankowski, et al.
Molecular Aspects of Medicine|August 18, 2021
Irreversible post-translational modifications - Emerging cardiovascular risk factorsZhuojun Wu, Vera Jankowski, Joachim Jankowski
Frontiers in Immunology|July 29, 2015
Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its ComorbiditiesPrathibha Reddy Gajjala, Maryam Sanati, Joachim Jankowski
Seminars in Dialysis|August 28, 2009
Proteomics in uremia and renal diseaseHarald Mischak, Ziad A Massy, Joachim Jankowski
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2015
Body fluid peptide and protein signatures in diabetic kidney diseasesJoachim Jankowski, Joost P Schanstra, Harald Mischak
Nature Reviews. Nephrology|May 11, 2021
Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterationsHeidi Noels, Michael Lehrke, Raymond Vanholder, et al.
Pageof 22